News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
FDA Panel Urges More Testing for Diabetes Drugs
July 28, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
NEW YORK (Associated Press) - Diabetes drugs should face tougher safety standards that could cost manufacturers millions but protect patients from unforeseen heart risks, a government panel has recommended.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Regulatory
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Regulatory
FDA To Publish Drug-Related Adverse Event Reports Daily
August 25, 2025
·
2 min read
·
Tristan Manalac
Approvals
Ionis Wins Approval For First RNA-Targeted Prophylactic for Rare Swelling Disease
August 22, 2025
·
2 min read
·
Tristan Manalac
Regulatory
After Court Win, Vanda Asks Makary To Review ‘Unacceptable’ Approval of Rival Generics
August 22, 2025
·
2 min read
·
Tristan Manalac
Regulatory
Krystal Cuts Melanoma Study of Viral Immunotherapy as FDA ‘Uncertainty’ Muddies Approval Pathway
August 22, 2025
·
2 min read
·
Tristan Manalac